Although the thymus has long been recognized as a key organ for T cell selection, the intricate details linking these selection events to human autoimmunity have been challenging to decipher. Over the last two decades, there has been rapid progress in understanding the role of thymic tolerance mechanisms in autoimmunity through genetics. Here we review some of the recent progress in understanding key thymic tolerance processes that are critical for preventing autoimmune disease.
T he prevention of autoimmunity is a major challenge for the adaptive immune system. Stochastic generation of the T cell receptor (TCR) in individual thymocytes during thymic development invariably results in the generation of individual clones with the potential for autoreactivity. Although it has long been hypothesized that the removal of such clones from the T cell repertoire in the thymus is crucial for the prevention of autoimmunity, it has only been in the last two decades that clear evidence has been achieved for a key role of thymic central tolerance in preventing autoimmunity. In this Review, we highlight some of the recent advances in understanding of the cellular and molecular processes that control central T cell tolerance and the growing evidence for a relationship between thymic central tolerance and autoimmune diseases.
The autoimmune regulator (Aire): a direct link of central tolerance with autoimmunity
During their development in the thymus, thymocytes with high self-reactivity are deleted and removed from the T cell repertoire through negative selection 1, 2 . In spite of this knowledge, directly linking a breakdown in this important mechanism to the development of clinical autoimmunity had been a persistent challenge until identification of the autoimmune regulator (Aire) gene as a key promoter of the expression of self-antigens within the thymus [3] [4] [5] . Aire was originally identified as the defective gene product in the Mendelian autoimmune syndrome called autoimmune polyglandular syndrome type 1 (APS1) in a positional cloning effort 6, 7 . Patients with APS1 develop autoimmunity that targets many individual organs, with a predilection for destruction of the adrenal and parathyroid glands 8, 9 . Interestingly, these patients also frequently develop susceptibility to mucocutaneous candidiasis, which is now associated with an autoimmune response to T helper type 17 (T H 17)-related cytokines 10, 11 . Anti-cytokine autoantibodies to type 1 interferons are found in > 99% of patients with APS1, and antibodies to interferon (IFN)-α are virtually diagnostic for the syndrome 12 .
Whether these interferon-targeting autoantibodies are pathogenic or protective remains unclear, although recent correlation of neutralizing interferon-targeting antibodies with reduced incidence of type 1 diabetes in patients with APS1 suggests that such autoantibodies may in part mediate a potential protective role 13 . Major clues about Aire function came from mapping its gene expression pattern and the development of a knockout mouse model. Aire is highly expressed in medullary thymic epithelial cells (mTECs) and to a lesser extent in thymic B cells and in a peripheral dendritic cell population [14] [15] [16] [17] . Although such Aire-expressing peripheral dendritic cells and thymic B cells can serve as antigenpresenting cells (APCs) to mediate antigen-specific deletional tolerance mechanisms [16] [17] [18] , it remains unclear what the relative contribution of these smaller cell subsets is to enforcing thymic tolerance measures. Within mTECs, Aire helps promote the expression of thousands of tissue-specific self-antigens (TSAs) for display to the developing T cell repertoire, and there is now evidence that this display drives both the deletion of autoreactive T cells [19] [20] [21] and the positive selection of a subset of self-reactive T regulatory (T reg ) cells [22] [23] [24] . Similarly to the mouse model, patients with APS1 demonstrate autoantibodies to a wide array of TSAs 13, 25 with development of targeted organ-specific autoimmunity [26] [27] [28] , although the specific antigenic targets and spectrum of organ-specific autoimmunity differ somewhat from those in the mouse model 29 . Thus, the Aire model of APS1 has provided the strongest evidence thus far for a relationship between a defect in central tolerance and the generation of autoimmunity in humans.
mTECs, display of self-antigens and the activity of Aire
The population of mTECs has many unique properties, and study of the development and gene expression pattern of these cells has been a renewed area of interest. The mTEC compartment can be broadly segregated into sets of cells expressing low versus high levels of major histocompatibility complex (MHC) class II (mTEC lo and mTEC hi ) [30] [31] [32] [33] . It now appears that a subset of mTEC lo cells are destined to mature into mTEC hi cells, which then also acquire Aire expression through RANK-RANK ligand (RANKL)-mediated signals [34] [35] [36] . In adult mice, this developmental pathway is remarkably dynamic, with the half-life of Aire-expressing mTEC hi cells being about 12-14 days 31, 37 . Thus, every two weeks, a new pool of mTEC hi cells is generated within the medulla. This dynamic turnover may be in place to help ensure the consistent display of TSAs to developing thymocytes, especially because of heterogeneity in TSA expression in the mTEC pool (see below). Interestingly, in vivo blockade of RANKL with monoclonal antibody treatment in adult mice over two weeks can lead to selective depletion of mTECs from the thymus and an induced defect in negative selection 38 . Consistent with these findings, studies with an Aire-driven reporter system also suggest that the majority of mTECs are on a developmental pathway to acquire Aire expression 39 , and continued blockade of RANKL would thus be expected to significantly deplete the mTEC pool. Despite the defect in negative selection in anti-RANKL-treated mice, the mice do not succumb to spontaneous autoimmunity, and this may have to do with other peripheral tolerance mechanisms such as T reg cells in the tissues that hold newly generated autoreactive cells in check in the periphery 24 . Regardless, it will be interesting to determine whether patients who are treated with anti-RANKL monoclonal antibodies, which are widely used in the treatment of osteoporosis, show increased susceptibility to autoimmunity. While an increased frequency of sinus and upper respiratory infections is noted with the anti-RANKL agent denosumab, which has been in use since 2010 for treatment of postmenopausal osteoporosis or skeletal-related complications in cancers with metastatic bone disease, reports of autoimmunity have been lacking thus far, although Review ARticle | FOCUS NATure ImmuNOlOgy absence of autoimmunity may be confounded by the advanced age of patients, relatively infrequent dosing (for example, every six months) or differences in dose effect on different cell subtypes. A more intriguing possibility is that it may be possible to also harness the effects of RANKL blockade to improve immune responses against tumor antigens 38, 40 . The properties of the mTEC hi pool of cells have been a source of intense study (Fig. 1a) , and recent studies using single-cell RNA sequencing (RNA-seq) have revealed that the nature of expression of Aire-dependent TSAs within these cells is both stochastic and ordered 41, 42 . It now appears that only a small fraction of mTECs express a particular TSA (1-3%), which highlights the stochastic feature of expression within the pool of mTEC hi cells. At the same time, within individual cells, a general pattern of multiple coexpression of sets of TSAs can be identified. For the most part, these coexpression sets often have little in common and do not reflect how these TSAs are expressed in peripheral tissues. Epigenetic studies have shown that these TSAs are in open chromatin conformations and that looping of the chromatin between chromosomes correlates with coexpression properties 43 . Aire has been shown to be greatly enriched at super-enhancers within mTECs along with other chromatin regulators, particularly the topoisomerases TOP1 and TOP2, which are involved in the unwinding of DNA 44, 45 . Aire had previously been implicated as interacting with topoisomerase family members, but through depletion studies it now appears that TOP1 is the primary topoisomerase to which Aire binds 44 and this interaction helps drive the localization of Aire to super-enhancers where other factors that include elements involved in DNA doublestrand break repair can interact to promote transcription of Aire target genes 46 . Finally, Aire has also been demonstrated to promote transcriptional elongation of RNA polymerase II through its interaction with the transcriptional regulator pTEFb 47, 48 . Thus, through localization of Aire to super-enhancers that include chromosomal looping, a wide number of genes in this local environment can be transcribed. Taken together, a picture is emerging that a complex series of epigenetic events are required for Aire to promote the expression of TSAs (for further detail, see refs 49, 50 ).
Fezf2: an Aire-like transcription factor
Studies on gene expression of mTECs have also shown that a wide array of TSAs continue to be expressed in Aire -/-mTECs 3, 51 . This observation has led to the attractive hypothesis that other transcription factors are present and operate in mTECs to promote the expression of TSAs (Fig. 1b) . Forebrain-expressed zinc finger 2 (Fezf2) has been implicated as such a transcription factor 52 . Fezf2 was identified by screening for transcription factors that were differentially expressed between cortical thymic epithelial cells (cTECs) and mTECs. Fezf2 is highly expressed in the brain and has an important role in the differentiation and development of corticospinal neurons 53 . Germline knockout mice of Fezf2 die shortly after birth, and the role of Fezf2 in the thymus or immune system had not been studied until recently 52 . The thymus in Fezf2 -/-neonatal mice is reported to be relatively normal, with appropriate expression of Aire, distribution of mTEC lo and mTEC hi cells, and normal thymocyte population numbers and percentages. Within mTECs, Fezf2 appears to promote the expression of an array of TSAs that are distinct from the Aire-dependent TSAs. Furthermore, in both thymic grafting experiments with Fezf2 -/-thymi and TEC-specific knockouts of Fezf2, mice developed spontaneous autoimmunity with evidence of tissue organ infiltrates and autoantibodies in a spectrum distinct from that seen with Aire -/-mice. In addition, it was suggested that the induction of Fezf2 expression in mTECs was dependent on lymphotoxin β signaling whereas that of Aire-expressing mTECs was mainly dependent on RANK-induced signals. More recent data have called into question the role of lymphotoxin β , as it was found that TEC-specific deletion of the lymphotoxin β receptor (LTβ R TEC ) did not ablate the development of either Fezf2-or Aireexpressing mTECs 54 . In this study, it was found that RANK-RANKL signals were crucial for the development of both Aire-and Fezf2-expressing cells. Nonetheless, the medulla of LTβ R TEC mice showed a decreased frequency of mTECs and smaller islands of medullary areas. Interestingly, in the same study, in contrast to the TECspecific loss of LTβ R, mice with germline inactivation of LTβ R (Ltbr --/-) showed evidence of generating autoimmunity in thymic grafting experiments and defects in both medullary organization and the frequency of medullary dendritic cell populations. These results suggest a complex role for LTβ R in both the mTEC and dendritic cell compartments in the medulla. Overall, further work will be needed to determine the exact mechanisms by which Fezf2 operates within mTECs, directly linking Fezf2 defects to human autoimmune disease, and whether there are other similar factors that promote the expression of self-antigens within the medulla.
Thymic selection of T reg cells, Aire and autoimmunity
Although there are extensive data showing a clear role for Aireinduced TSA display in promoting the negative selection of autoreactive T cells [19] [20] [21] , the role of Aire in promoting T reg cell selection has come back into focus. In previous work, forced expression of model self-antigens in Aire-expressing mTECs could induce positive selection of Foxp3-expressing T reg cells in a TCR-transgenic model 55 .
In contrast, the frequency and general function of T reg cells in the thymus and periphery of adult Aire-deficient mice appear relatively normal 24, 56 . More detailed studies on the TCR repertoire of T reg cells from Aire-deficient versus wild-type hosts with a limited repertoire system have provided new evidence that a subset of the TCR repertoire in T reg cells is dependent on Aire 22, 23 . At the same time, many T reg cell-specific TCRs do not appear to rely at all on Aire for their ; rather, cells with specificity for IRBP appear to be absent, suggesting strong induction of negative selection. Clearly, more work will be needed to determine the nature of TSA display within the thymus by mTECs that induces negative selection versus T reg cell selection and how such selection drives or prevents autoimmunity. Likewise, there has also been work showing that, during the neonatal period in mice, there is a decreased frequency of T reg cells within the thymus of Aire-deficient hosts 24 . Elaborate T reg cell transfer studies in this time window suggest that this may be part of the cellular mechanism by which autoimmunity ensues in the Aire-deficient model. At the same time, previous work by two independent groups showed that simultaneous co-transfer of Aire +/+ and Aire -/-thymi into nude mouse hosts did not protect against autoimmunity that favors defects in deletional mechanisms rather than a dominant tolerance mechanism as the primary trigger for autoimmunity in the model 20, 58 . Again, more detailed study of the TCR specificities that emerge in T reg cells and the conventional T cell pool and their relationship with autoimmunity will have to be worked out to resolve these issues.
PSMB11, positive selection of CD8 + T cells and links to autoimmunity
Within the cortex of the thymus, the display of MHC-peptide ligands is crucial for positive selection of developing thymocytes. Generation of peptide ligands for MHC class I molecules is likely to be unique because of the expression of a thymus-specific proteasome subunit known as β 5t (encoded by Psmb11) mainly in cTECs. β 5t is a catalytic subunit of the proteasome that has chymotrypsinlike activity and whose presence is critical for positive selection by cTECs 59 . β 5t has lower chymotrypsin-like activity than other such subunits in the immuneproteasome, and it thus likely helps produce a different array of peptide ligands for MHC class I loading in cTECs than those present outside of the thymus. A translational approach has been used to model human variants of β 5t in mice 60 .
Here the researchers found that human β 5t variants knocked into mice could indeed alter thymic positive selection and the array of peptides being displayed by cTECs. Interestingly, this process may have a link to autoimmunity, as a single-nucleotide polymorphism (SNP) that results in a G49S variant is associated with the development of Sjögren's syndrome and also impairs positive selection of CD8 + T cells in the mouse model. More work will have to be done on the specific selection events that give rise to autoreactive T cells with this specificity, but these results underscore a relationship between cTEC-driven positive selection and autoimmune disease.
Impaired T cell signaling and defective thymic tolerance
During their transit through the thymic maturation process, T cells display dynamic changes in the levels of cell-surface TCR and signaling components to help guide the positive and negative selection process. Zap70 is a tyrosine kinase and critical T cell signaling molecule whose expression is upregulated during thymocyte maturation. Loss of Zap70 is associated with severe immune deficiency, comprising the absence of CD8 + T cells and impaired CD4 + T cells. Previous work on a spontaneous mutant mouse line, termed SKG, identified a mutation in Zap70 that was associated with autoimmunity and a defect in thymic selection 61, 62 . In a large body of work, it now appears that this allele has hypomorphic activity, causing Zap70 activity to be impaired but not blocked. Within the thymus, this results in an increased threshold for positive selection, such that only more autoreactive T cells can pass through this selection step. At the same time, negative selection is also impaired, and in the end a more autoreactive repertoire is generated (Fig. 2 ). This elegant model has now been extended into a series of Zap70 alleles that cover a spectrum of hypomporphic activity in mouse models and highlight how altering TCR signaling thresholds in the thymus can promote the production of an autoreactive T cell repertoire, an altered T reg cell repertoire (Fig. 2) and autoimmunity (for a more thorough discussion, see refs 63, 64 ). A novel human autoimmune syndrome was described in a single kindred with two hypomorphic ZAP70 alleles, underscoring the role of this mechanism in promoting autoimmunity 65 . The affected siblings in this kindred developed autoimmunity in the kidneys and skin. Whole-exome sequencing of the family revealed that the affected siblings each harbored two mutant ZAP70 alleles, one with a mutation encoding R192W and the other with a mutation encoding R360P. Detailed analysis of these mutant alleles revealed that the Zap70 mutant with an R192W substitution in the SH2 domain had reduced binding to Review ARticle | FOCUS NATure ImmuNOlOgy the CD3ζ chain while the R360P substitution in the kinase domain disrupted autoinhibitory function. Thus, when both alleles are present, Zap70 signaling is likely to be somewhat decreased and to follow the autoimmune model developed in the mouse studies on hypomorphic Zap70 alleles. Of course, in this human example, it is difficult to determine the contribution of thymic versus peripheral defects in generating the autoimmune phenotype seen, and factors such as lymphopenia could have an important triggering role. Nonetheless, the preponderance of mouse data suggests that, at least in part, an altered thymic repertoire is responsible for the break in tolerance (Fig. 2) .
Altered thymic architecture and autoimmunity
The role of central tolerance is notable also in examples of disease states associated with altered thymic architecture or function (reviewed in ref. 66 ), as seen with thymoma and in myasthenia gravis. Thymomas are highly associated with a wide variety of organ-specific and systemic autoimmune diseases (reviewed in ref. 67 ). Notably, 95% of thymomas fail to express Aire, suggesting that disordered thymic selection contributes to the paraneoplastic autoimmunity seen in these cases through loss of Aire-mediated effects on thymic epithelial development and TSA expression [68] [69] [70] . Myasthenia gravis is frequently seen in association with thymoma along with the presence of anti-cytokine autoantibodies to type 1 interferons 71 . Although loss of Aire expression is thought to contribute to the autoimmune predilection in these subjects, it is worth noting that these individuals rarely develop the pattern of autoimmunity associated with APS1. Interestingly, thymic hyperplasia is also associated with myasthenia gravis, and these observations have led to the development of thymectomy as a clinical treatment for the disorder. Somewhat remarkably, thymectomy seems to be effective in significantly improving outcomes and reducing the need for immunosuppression in many patients with myasthenia gravis, even in the absence of overt thymoma 72 . The mechanism(s) by which this technique provides clinical benefit still remain to be worked out but could include blockade of the generation of new autoreactive T cells.
links to more common autoimmune disease settings
Finally, the discovery of common risk variants through directed genetic studies and genome-wide association studies (GWAS) provides further clues as to the contribution of thymic selection and central tolerance. Polymorphisms of the variable nucleotide tandem repeat (VNTR) region of the insulin promoter lead to variable thymic expression of insulin and are linked to risk for development of type 1 diabetes 73 , and Aire-mediated expression of CHRNA1 (cholinergic receptor nicotinic α 1 subunit), which encodes the acetylcholine receptor autoantigen, is linked to risk for development of myasthenia gravis 74 . It is also worth noting that GWAS on myasthenia gravis have identified variants in RANK as a risk factor 75 . In all of these cases, the relationship of these more common risk variants with thymic selection has been greatly strengthened through detailed study of rare Mendelian forms of autoimmunity like APS1, highlighted above. For example, it is now clear that Aire promotes the expression of insulin in the thymus, providing a more detailed mechanism of how the VNTR risk variant in the insulin promoter is likely connected to diabetes risk. Likewise, the myasthenia gravis risk variant in RANK can be more closely tied to mTECs, given what has been learned about the key role of RANK in mTEC maturation, as outlined above.
It is also worth noting the patterns of autoimmunity in the human conditions linked to the mechanisms highlighted here. For instance, patients with APS1 tend to develop parathyroid and adrenal gland autoimmunity, but patients with thymoma develop myasthenia gravis. Likewise, the autoimmune clinical pattern in patients with hypomorphic Zap70 activity is also distinct. Clearly, there is more work to do in unraveling the mechanisms and steps in play here that ultimately lead to these autoimmune phenotypes. Overall, the last two decades have seen major progress in characterizing key events in thymic tolerance and linking them to autoimmune predisposition. Looking forward, the challenge remains of how to harness this information for the treatment and prevention of autoimmunity. Although it may be a difficult path forward, one can now imagine strategies that selectively target mTECs and TSA expression through targeting of RANK-RANKL signaling or reconstruction and repair of the thymus through stem cell approaches 76 . In the latter case, this could also be coupled with genetic engineering approaches such as CRISPR-Cas9 to enhance TSA expression or Aire function. Together, such approaches could have major implications for the induction of tolerance and prevention of autoimmunity.
